Related Experiment Videos
Therapeutic implications of the TGF-beta system
1Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire, USA. Bradley.Arrick@dartmouth.edu
Abstract:
This review considers the various roles of the TGF-beta system in mammary carcinogenesis, tumor progression, and cellular responses to therapeutic measures. The paradigm that has evolved from the work of many investigators suggests that loss of tumor cell responsiveness to the effects of TGF-beta can result in a crucial shift in the net effect of TGF-beta within the context of the tumor-host interaction. Principal elements of host-tumor interactions in which this shift may play out, including immune suppression, angiogenesis, and modification of the surrounding extracellular matrix by tumor cells, are potentially amenable to manipulation. Additional effects of TGF-beta, such as suggested by reports of its ability to alter the drug resistance of tumor cells and the drug sensitivity of normal tissues, suggest that appropriate molecular intervention designed to affect the TGF-beta system might constitute an effective therapeutic strategy.
Insights
Transforming growth factor-beta (TGF-beta) plays a dual role in breast cancer. Loss of tumor cell responsiveness to TGF-beta can shift its effects, impacting tumor progression and therapy responses.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- The transforming growth factor-beta (TGF-beta) system is implicated in various biological processes, including cell growth, differentiation, and immune responses.
- Its role in mammary carcinogenesis and tumor progression is complex and context-dependent.
- Understanding TGF-beta's influence on the tumor microenvironment and therapeutic responses is crucial.
Purpose of the Study:
- To review the multifaceted roles of the TGF-beta system in mammary gland cancer.
- To explore how TGF-beta influences tumor progression and host-tumor interactions.
- To discuss the implications of TGF-beta signaling in cellular responses to cancer therapies.
Main Methods:
- This review synthesizes existing research and literature on the TGF-beta system in breast cancer.
- It analyzes the shift in TGF-beta's net effect upon loss of tumor cell responsiveness.
- Key aspects of host-tumor interactions influenced by TGF-beta are examined.
Main Results:
- Loss of tumor cell responsiveness to TGF-beta can lead to a critical shift in its function within the tumor-host interaction.
- This shift impacts immune suppression, angiogenesis, and extracellular matrix remodeling by tumor cells.
- TGF-beta may also modulate tumor cell drug resistance and normal tissue drug sensitivity.
Conclusions:
- TGF-beta signaling is a key regulator in mammary carcinogenesis and progression.
- Altered TGF-beta responsiveness in tumor cells can promote a pro-tumorigenic microenvironment.
- Targeting the TGF-beta system presents a potential therapeutic strategy for breast cancer treatment.